• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于色谱法测定细胞毒性有效载荷药物的摩尔消光系数及抗体药物偶联物的药物抗体比的方法。

Chromatography-based methods for determining molar extinction coefficients of cytotoxic payload drugs and drug antibody ratios of antibody drug conjugates.

作者信息

Wang Chunlei, Chen Sike, Caceres-Cortes Janet, Huang Richard Y-C, Tymiak Adrienne A, Zhang Yingru

机构信息

Research & Development, Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, United States.

Research & Development, Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, United States.

出版信息

J Chromatogr A. 2016 Jul 15;1455:133-139. doi: 10.1016/j.chroma.2016.05.086. Epub 2016 May 26.

DOI:10.1016/j.chroma.2016.05.086
PMID:27286648
Abstract

UV spectrophotometry is widely used to determine the molar extinction coefficients (MECs) of cytotoxic drugs as well as the drug antibody ratios (DARs) of antibody drug conjugates (ADCs). However, the unknown purity of a drug due to interfering impurities can lead to erroneous MECs and DARs. Hence, reliable methods to accurately determine purity and the MECs of drugs with limited quantity is urgently needed in Drug Discovery. Such a method has been developed. It achieves absolute purity and accurate MEC determination by a single automated HPLC analysis that uses less than 5μg of material. Specifically, analytical HPLC separation with online UV detection was used to resolve impurities and measure absorbance from only the compound of interest. Simultaneously, an online chemiluminescence nitrogen detector (CLND) was used to determine the concentration of the analyte. The MECs were then calculated from the absorbance and concentration results. The accuracy of the method was demonstrated using caffeine and a commercial cytotoxic drug, DM1. This approach is particularly suited to analyzing mixtures or samples with low purities. Excellent reproducibility was demonstrated by analyzing a proprietary drug with linker synthesized from different batches with very different levels of purity. In addition, the MECs of drug with linker, along with ADC peak areas measured from size exclusion chromatography (SEC), were used to calculate DARs for 21 in-house ADCs. The DAR results were consistent with those obtained by MS analysis.

摘要

紫外分光光度法被广泛用于测定细胞毒性药物的摩尔消光系数(MEC)以及抗体药物偶联物(ADC)的药物抗体比(DAR)。然而,由于干扰杂质导致药物纯度未知,可能会导致错误的MEC和DAR。因此,药物研发中迫切需要可靠的方法来准确测定有限量药物的纯度和MEC。这样一种方法已经被开发出来。它通过单次自动高效液相色谱(HPLC)分析实现了绝对纯度和准确的MEC测定,该分析使用的材料少于5μg。具体而言,采用带有在线紫外检测的分析型HPLC分离来分离杂质,并仅测量目标化合物的吸光度。同时,使用在线化学发光氮检测器(CLND)来测定分析物的浓度。然后根据吸光度和浓度结果计算MEC。使用咖啡因和一种市售细胞毒性药物DM1证明了该方法的准确性。这种方法特别适合分析低纯度的混合物或样品。通过分析由不同批次合成的具有非常不同纯度水平的连接子的专利药物,证明了出色的重现性。此外,带有连接子的药物的MEC以及从尺寸排阻色谱(SEC)测得的ADC峰面积,被用于计算21种内部ADC的DAR。DAR结果与通过质谱分析获得的结果一致。

相似文献

1
Chromatography-based methods for determining molar extinction coefficients of cytotoxic payload drugs and drug antibody ratios of antibody drug conjugates.基于色谱法测定细胞毒性有效载荷药物的摩尔消光系数及抗体药物偶联物的药物抗体比的方法。
J Chromatogr A. 2016 Jul 15;1455:133-139. doi: 10.1016/j.chroma.2016.05.086. Epub 2016 May 26.
2
Maytansinoid-BODIPY Conjugates: Application to Microscale Determination of Drug Extinction Coefficients and for Quantification of Maytansinoid Analytes.美登素类-硼二吡咯共轭物:在微量测定药物消光系数及美登素类分析物定量中的应用。
Mol Pharm. 2015 Jun 1;12(6):1745-51. doi: 10.1021/mp500843r. Epub 2015 Mar 16.
3
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.曲妥珠单抗(ado-曲妥珠单抗)的天然质谱和离子淌度表征,一种赖氨酸连接的抗体药物偶联物 。
Protein Sci. 2015 Aug;24(8):1210-23. doi: 10.1002/pro.2666. Epub 2015 Mar 31.
4
A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.一种用于抗体药物偶联物稳定性及小分子相关物质分析的尺寸排阻-反相二维液相色谱方法。
J Chromatogr A. 2015 May 8;1393:81-8. doi: 10.1016/j.chroma.2015.03.027. Epub 2015 Mar 16.
5
Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.采用正交试验方案评估抗体药物偶联物曲妥珠单抗-美坦新与亲本单克隆抗体的稳定性。
J Pharm Biomed Anal. 2018 Feb 20;150:268-277. doi: 10.1016/j.jpba.2017.12.022. Epub 2017 Dec 13.
6
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.药物-抗体比例对抗体-美登素类偶联物药代动力学、生物分布、疗效和耐受性的影响
Bioconjug Chem. 2017 May 17;28(5):1371-1381. doi: 10.1021/acs.bioconjchem.7b00062. Epub 2017 Apr 13.
7
Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels.天然尺寸排阻色谱-质谱法:适用于各种化学型和载药量的抗体药物偶联物药物抗体比定量分析。
MAbs. 2020 Jan-Dec;12(1):1682895. doi: 10.1080/19420862.2019.1682895.
8
Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.采用纳升液相色谱-高分辨质谱联用的特征离子指纹图谱和归一化面积定量方法分析抗体药物偶联物(ADCs)的缀合位点。
Anal Chim Acta. 2017 Feb 22;955:67-78. doi: 10.1016/j.aca.2016.11.073. Epub 2016 Dec 2.
9
Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.利用组织蛋白酶B消化结合反相高压液相色谱分析来测定抗体药物偶联物的药物与抗体比例。
J Chromatogr A. 2017 Jan 20;1481:44-52. doi: 10.1016/j.chroma.2016.12.051. Epub 2016 Dec 19.
10
Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.采用偶联液相色谱-表面等离子体共振生物传感技术对单克隆抗体和抗体药物偶联物制剂进行亲合力分析。
Anal Bioanal Chem. 2018 Dec;410(30):7837-7848. doi: 10.1007/s00216-018-1414-y. Epub 2018 Oct 17.

引用本文的文献

1
Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer.一种用于治疗三阴性乳腺癌的新型核糖核酸酶H2抑制剂的药物代谢与药代动力学评价
Pharmaceutics. 2025 Aug 13;17(8):1052. doi: 10.3390/pharmaceutics17081052.
2
Biocatalytic Carbon-Hydrogen and Carbon-Fluorine Bond Cleavage through Hydroxylation Promoted by a Histidyl-Ligated Heme Enzyme.通过组氨酸连接的血红素酶促进的羟基化实现生物催化的碳-氢键和碳-氟键裂解
ACS Catal. 2019 Jun 7;9(6):4764-4776. doi: 10.1021/acscatal.9b00231. Epub 2019 Apr 11.